Daphne Tak Wai Lo, MD | |
117 N San Mateo Dr Ste 1, San Mateo, CA 94401-2794 | |
(650) 425-9408 | |
Not Available |
Full Name | Daphne Tak Wai Lo |
---|---|
Gender | Female |
Speciality | Internal Medicine - Geriatric Medicine |
Location | 117 N San Mateo Dr Ste 1, San Mateo, California |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1730470121 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0300X | Internal Medicine - Geriatric Medicine | A130632 (California) | Primary |
Entity Name | Healthright 360 |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760427843 PECOS PAC ID: 3678674025 Enrollment ID: O20070730000160 |
News Archive
Sound Physicians, a leading hospitalist organization focused on measurably improving the quality, satisfaction, efficiency and financial performance of healthcare delivery, today announced the availability of its Value-Based Purchasing Performance Assessment Tool to all hospitals at no cost.
Scientists from King's College London, funded by Breast Cancer Now, believe they have found a way to identify lymph-node positive breast cancer patients who are most likely to develop incurable secondary tumours (metastases) and those who are less at risk.
Marking a milestone in the evolution of fully-bioresorbable drug-eluting scaffolds for interventional cardiology, the first commercial implant of Elixir Medical's CE Mark-approved DESolve Novolimus Eluting Coronary Scaffold was performed in Germany by Professor Dr. med. Holger Nef, Head of the Cardiac Catheterization Laboratory, University Hospital Giessen, Giessen, Germany.
Sequella, Inc., a clinical-stage biopharmaceutical company focused on commercializing products to treat life-threatening infectious diseases, today announced that it amended an existing agreement with the National Institutes of Health (NIH) to significantly broaden the licensed therapeutic indications, or "field of use," for Sequella's lead drug candidate, SQ109.
An analysis of 48,785 HIV-positive patients enrolled in China's National Free Antiretroviral Treatment Program over a five-year period revealed that "[h]alf of China's AIDS patients stopped responding to treatment over five years and didn't have access to the back-up drugs available in developed nations," according to an Annals of Internal Medicine study, Bloomberg reports.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Daphne Tak Wai Lo, MD 117 N San Mateo Dr Ste 1, San Mateo, CA 94401-2794 Ph: (650) 425-9408 | Daphne Tak Wai Lo, MD 117 N San Mateo Dr Ste 1, San Mateo, CA 94401-2794 Ph: (650) 425-9408 |
News Archive
Sound Physicians, a leading hospitalist organization focused on measurably improving the quality, satisfaction, efficiency and financial performance of healthcare delivery, today announced the availability of its Value-Based Purchasing Performance Assessment Tool to all hospitals at no cost.
Scientists from King's College London, funded by Breast Cancer Now, believe they have found a way to identify lymph-node positive breast cancer patients who are most likely to develop incurable secondary tumours (metastases) and those who are less at risk.
Marking a milestone in the evolution of fully-bioresorbable drug-eluting scaffolds for interventional cardiology, the first commercial implant of Elixir Medical's CE Mark-approved DESolve Novolimus Eluting Coronary Scaffold was performed in Germany by Professor Dr. med. Holger Nef, Head of the Cardiac Catheterization Laboratory, University Hospital Giessen, Giessen, Germany.
Sequella, Inc., a clinical-stage biopharmaceutical company focused on commercializing products to treat life-threatening infectious diseases, today announced that it amended an existing agreement with the National Institutes of Health (NIH) to significantly broaden the licensed therapeutic indications, or "field of use," for Sequella's lead drug candidate, SQ109.
An analysis of 48,785 HIV-positive patients enrolled in China's National Free Antiretroviral Treatment Program over a five-year period revealed that "[h]alf of China's AIDS patients stopped responding to treatment over five years and didn't have access to the back-up drugs available in developed nations," according to an Annals of Internal Medicine study, Bloomberg reports.
› Verified 8 days ago
Kent Marc-josef Adler, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 218 De Anza Blvd, San Mateo, CA 94402 Phone: 650-341-9131 Fax: 650-341-9135 | |
Stanley Cheung-kit Hui, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 222 W 39th Ave, San Mateo, CA 94403 Phone: 650-573-2222 | |
Donald Bernard Jaffe, M.D. Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 505 Hurlingham Ave, San Mateo, CA 94402 Phone: 650-342-6977 Fax: 650-343-4074 | |
Lisa Gooze, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 222 W 39th Ave, San Mateo, CA 94403 Phone: 650-573-2222 | |
Vivian Levy, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 222 W 39th Ave, San Mateo, CA 94403 Phone: 650-573-2222 | |
Dr. Tina Au, Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 222 W 39th Ave, San Mateo, CA 94403 Phone: 650-573-3702 | |
Robert Lawrence Cohen, MD Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 660 Parrott Dr, San Mateo, CA 94402 Phone: 650-342-4357 |